Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by wasagastaron Jun 30, 2017 10:06pm
152 Views
Post# 26426528

RE:RE:Press Release

RE:RE:Press Release
Mark71cl wrote: Just reading this TLT NR now. Wow, not a lot of ways to spin this one. It would appear that the Ontario government now has a history of RW and his PR accuracy. Their latest message to RW, "Tell the truth". I only go back as far as 2014 not 2010 but I still remember the 10 or so interviews RW gave in early 2014 where he clearly indicated a Ph1/2b with 30 patients beginning at start of 2015. I'd forgotten about all of the embellishment on the laser side but did clip the following out of today's PR: "The Corporation has experienced slower than expected sales growth of the TLC-2000. As previously disclosed, the Corporation recorded annual revenues of $1,918,893 for fiscal year 2016 and is not expected to achieve its objective of $10 million in annual sales for fiscal year 2017 or aggregate sales of $30 to 50 million for the next 3 to 5 years or any other forward looking targets with respect to revenue which may have been previously provided." Yeah, that was Roger who had projected sales of $10 million that only amounted to $2 million. Poor guy can't try to buffalo the shareholder anymore. God Bless the Ontario Securities people. Even Mr. Bencro can't spin this NR.


calling out Bencro for this failure of TLC2000 sales?  Idiot.  Get a grip. Get lost. 

Bullboard Posts